Results of the Post-U.S. Food and Drug Administration-Approval Study With a Continuous Flow Left Ventricular Assist Device as a Bridge to Heart Transplantation: A Prospective Study Using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support)

Study Questions:

Are morbidity and mortality rates following implantation of the HeartMate II (HMII) left ventricular assist device (LVAD) comparable to that of other devices implanted in the same era for the bridge to transplant indication?